- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02429336
Characteristics of Women With Reproductive Concerns
Clinical Characteristics of Women Presenting to the Reproductive Endocrinology Clinic
The purpose of this study is to collect data that will be generated during an office visit. The data will be gathered and analyzed in research studies that will help with the investigators understanding of various medical conditions.
About 200 subjects will be participating in this study. Participation in this study will not require a patient's time or presence. The medical information contained in a patient's chart from the office visit, including the results of any tests that were ordered at that time, will be transferred to an anonymous database and analyzed together with data from other patients who have similar condition/s.
No follow-up information will be collected. The following information will be collected from a patient's medical record: the medical history and a list of the current medications.
Study Overview
Status
Detailed Description
Purpose: To collect the characteristics of patients presenting to the reproductive endocrinology clinic.
Rationale: Patients' characteristics will be analyzed as part of clinical research studies and may help in understanding the causes of their condition.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Tennessee
-
Memphis, Tennessee, United States, 38103
- Regional One Health Ob-Gyn Clinic
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- females of childbearing potential experiencing reproductive endocrinology related problems
Exclusion Criteria:
- male or female not of childbearing potential
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Data collection from patients' charts.
Time Frame: up to 1 year from the time of signing the informed consent for data collection
|
Data collection from patients' charts.
|
up to 1 year from the time of signing the informed consent for data collection
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Laura Detti, M.D., Associate Professor, UTennessee Health Science Center
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 11-01368-XP
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Endocrine Disorders of Female Reproductive System
-
University of TennesseeCompletedEndocrine Disorders of Female Reproductive SystemUnited States
-
University of TennesseeCompletedSecondary Infertility | Endocrine Disorders of Female Reproductive System | Infertility InvoluntaryUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingFemale Reproductive CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingMetastatic Malignant Female Reproductive System NeoplasmUnited States
-
University of Wisconsin, MadisonNational Cancer Institute (NCI)CompletedFemale Reproductive CancerUnited States
-
Jonsson Comprehensive Cancer CenterAstraZenecaActive, not recruitingMetastatic Malignant Female Reproductive System Neoplasm | Platinum-Resistant Malignant Female Reproductive System Neoplasm | Recurrent Malignant Female Reproductive System Neoplasm | Refractory Malignant Female Reproductive System NeoplasmUnited States
-
Advocate Health CareTerminatedBenign Female Reproductive System NeoplasmUnited States
-
Liu WeifengNanfang Hospital of Southern Medical University; Second Affiliated Hospital... and other collaboratorsCompletedBenign Female Reproductive System NeoplasmChina
-
Seoul National University Bundang HospitalUnknownMalignant Female Reproductive System NeoplasmKorea, Republic of
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMalignant Female Reproductive System Neoplasm | Recurrent Malignant Female Reproductive System Neoplasm | Metastatic Cervical CancerUnited States